Is this your app? Claim this page to add your own description, links and contact info. It's free. →

Febrile Neutropenia Risk Tool at Mac App Store analyse

Portable Medical Technology Ltd

Reference Medical

0 ratings · Power index: 150

Free Mac App Store Follow Website

Version 1.6.1

Size 0 Bytes

Updated 6 years ago

Released 14 Dec 2015

How do you feel about this app?

Screenshots

Description

BeCOn Febrile Neutropenia Risk Assessment. The application allows you to assess if a patient undergoing chemotherapy is at risk of febrile neutropenia. Through a series of standardised questions based on EORTC and NCCN guidelines, the tool asks you consider the numerous factors that may contribute to an increased risk. Benefits ·It allows you to reference the EORTC and NCCN estimated risk associated with Febrile Neutropenia across all of the major chemotherapy regimes. ·All of the content is accessible via your mobile device, this means you can access the content “on the go”, to allow for fast, efficient decision making. BeCOn This tool is offered to you as part of Teva’s BeCOn initiative. BeCOn (Building Excellence and Continuity in Oncology Care) is our commitment to support the patient and the Health Care Professional across the continuum of care throughout the patient journey.

Estimates

Monthly Downloads > 3.3k

Est. Revenue ~ $1.35k

Share on X

Availability

Devices

iPhone4 iPad2Wifi iPad23G iPhone4S iPadThirdGen iPadThirdGen4G iPhone5 iPodTouchFifthGen iPadFourthGen iPadFourthGen4G iPadMini iPadMini4G iPhone5c iPhone5s iPadAir iPadAirCellular iPadMiniRetina iPadMiniRetinaCellular iPhone6 iPhone6Plus iPadAir2 iPadAir2Cellular iPadMini3 iPadMini3Cellular iPodTouchSixthGen iPhone6s iPhone6sPlus iPadMini4 iPadMini4Cellular iPadPro iPadProCellular iPadPro97 iPadPro97Cellular iPhoneSE iPhone7 iPhone7Plus iPad611 iPad612 iPad71 iPad72 iPad73 iPad74 iPhone8 iPhone8Plus iPhoneX

Pricing by country